The Evaluation of Artificial Intelligence in Lifestyle Management of Diabetic Patients in Community

Study Overview
=================
Brief Summary
-----------------
The goal of this clinical trial is to learn about the application and effectiveness evaluation of artificial intelligence (AI) in lifestyle management of diabetic patients in community.

Detailed Description
-----------------
To determine the effectiveness of lifestyle intervention through AI on diabetic patients, whether it can improve blood sugar/ blood pressure/ body weight/ blood lipid control in people with type 1 or type 2 diabetes? Then find related risk factors. Participants will complete the basic information, diet structure, use of dietary supplements, living habits, and exercise according to the AI scale (AI scale can be entered through we-chat mini program search), and provided personalized lifestyle intervention plan according to the survey result, while the control group received routine lifestyle guidance. All included patients would fill in the patient's medication information according to the information content of the machine reading card, and follow up whether the medication is adjusted. The patient was included in the diabetes management we-chat group, followed up for 3 months /6 months according to the visit plan. The experimental group filled in the lifestyle assessment scale again, and personalized lifestyle intervention programs were provided according to the survey results, while the control group received routine follow-up and lifestyle guidance. Researchers will compare the two groups to see if the control of blood glucose, blood pressure, blood lipids and BMI of the experimental group after 6 months of AI-based lifestyle intervention was better than the control group.

Official Title
-----------------
Application and Effectiveness Evaluation of Artificial Intelligence in Lifestyle Management of Diabetic Patients of Community

Conditions
-----------------
Diabetes

Intervention / Treatment
-----------------
* Behavioral: personalized lifestyle intervention by AI


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Well informed of the procedures of this trial and informed consent is obtained 18-80 years old, gender is not limited Diagnosed diabetes (according to WHO1999 diagnostic criteria) Well compliance Exclusion Criteria: Pregnant or lactating Poor blood glucose control (HbA1c>11%) A history of malignant tumor Abnormal liver or renal function [defined as alanine aminotransferase (ALT)>2.5 times higher than normal range, or eGFR<30 mL/min per 1.73 m2] Poor blood pressure control [systolic blood pressure (SBP)>180mmHg, or diastolic blood pressure (DBP)>110mmHg With severe heart disease, cardiac function worse than grade II, anemia (Hb<9.0g/d1) Blood routine test indicates that the white blood cell count (WBC) <3*109/L Body Mass Index (BMI)<18.5 or ≥35kg/m2 Drug or alcohol abuse Accompanying mental disorder who can't collaborate Abnormal digestion and absorption function Other endocrine diseases Other chronic diseases needed long-term glucocorticoid treatment With severe infection, immune dysfunction

Ages Eligible for Study
-----------------
Minimum Age: 18 Years
Maximum Age: 80 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Other
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Experimental: Intervention group<br>giving personalized lifestyle intervention suggestions through AI | Behavioral: personalized lifestyle intervention by AI<br>* The experimental group completed the basic information, diet structure, use of dietary supplements, living habits, and exercise according to the AI scale (AI scale can be entered through we-chat mini program search), and provided personalized lifestyle intervention plan according to the survey result.<br>|
| No Intervention: Control group<br>giving routine lifestyle suggestions | |

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Change of HbA1c | Change of HbA1c from baseline to endpoint (1 year follow-up) | one year | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Change of systolic blood pressure | Change of systolic blood pressure from baseline to endpoint | one year | 
| Change of diastolic blood pressure | Reduction of diastolic blood pressure from baseline to endpoint | one year | 
| Change of LDL-c | Change of LDL-c from baseline to endpoint | one year | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
lifestyle intervention, artificial intelligence